New Markers of Cardiac Surgery Related Acute Kidney Injury.

Pomeranian Medical University Szczecin

Status

Completed

Conditions

Cardiac Disease

Acute Kidney Injury

Treatments

Diagnostic Test: urine and blood analysis

Study type

Observational

Funder types

Other

Identifiers

NCT03860545

KB - 0012/146/10

Details and patient eligibility

About

Cardiac surgery related acute kidney injury (CS-AKI) is a clinical problem associated with a cardiopulmonary bypass used during cardiac surgery procedures. In this study the investigators will assess the biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules perioperatively. There has been no official recommendations toward routine use of analysed biomarkers.

Full description

Cardiac surgery related acute kidney injury (CS-AKI) is an important clinical problem. Kidney injury occurs following a cardiopulmonary bypass used during cardiac surgery procedures. The pathomechanisms of acute kidney injury (AKI) is complex and multifactorial. It may involve few injury pathways: ischemia and reperfusion, endogenous toxins, inflammation, metabolic factors and oxidative stress. Biochemical markers of acute kidney injury such as ischemia modified albumin (IMA) or urinary excreted of brush-border enzymes of the proximal renal tubules analysed perioperatively will be assessed in this study. There has been no official recommendations toward routine use of analysed biomarkers.

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

a planned operation of coronary artery bypass grafting with the use of cardiopulmonary bypass

Exclusion criteria

emergency operations or re-operations;
a known pathology of the urinary tract or renal failure;
chronic use of the following medications: iron, non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppression, or steroids in the preoperative period;
polycythemia, porphyria or pathological hemoglobin species in anamnesis;
preoperative signs of hepatic failure;
active autoimmune or neoplastic diseases, active infection;
anticipated significant bleeding (anti-platelet agents), suggesting the use of blood-derived products during the operation and afterward
acute myocardial infarction after operation